BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.04
-0.65 (-11.42%)
Sep 5, 2025, 4:00 PM - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.05 million as of September 5, 2025. Its market cap has increased by 21.26% in one year.
Market Cap
9.05M
Enterprise Value
6.21M
1-Year Change
21.26%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.05M, a decrease of -78.50%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 9.05M | 80.18% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
| Sep 16, 2020 | 42.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 220.16B |
| BHP Group | 138.65B |
| Rio Tinto Group | 107.98B |
| The Sherwin-Williams Company | 92.60B |
| Southern Copper | 83.64B |
| Newmont | 83.39B |
| Ecolab | 77.59B |
| Agnico Eagle Mines | 76.28B |